This may sound strange but on some level antiviral drug research is "easy." Make that "easy compared to other therapeutic areas," because those who work in the antiviral field – something I did for 10 ...

All-cause mortality risk did not significantly differ by HIV coinfection status in patients with chronic hepatitis C infection and advanced liver fibrosis who achieved sustained virologic response ...

Here, we review advances in our understanding of the HCV life cycle and associated opportunities for antiviral therapy. A new era in HCV treatment was heralded by the approval of first-generation ...

Emerging data suggest that antiviral therapy in the third trimester can prevent immunoprophylaxis failure. To minimize fetal exposure to antiviral agents, antiviral therapy during pregnancy should ...

He received his first dose of Paxlovid, an antiviral therapy produced by Pfizer. Earlier in the afternoon, Biden experienced upper respiratory symptoms, including a runny nose and nonproductive ...

Discover a new model predicting liver cancer risk in hepatitis B patients without cirrhosis. It identifies a nonlinear link ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”), a clinical stage global leader in broad-spectrum antiviral nanomedicines, today announces that Anil R. Diwan, Ph.D., the Company’s President ...

NanoViricides (NYSE American: NNVC) will present a corporate update at the Spartan Capital Investors <a target=_blank href= ...

A new study conducted by the Hepatitis Research Group at the Medical Research Council Unit The Gambia at the London School of ...